메뉴 건너뛰기




Volumn 17, Issue 8, 2011, Pages 1082-1087

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer

Author keywords

Advanced gastric cancer; Oxaliplatin; Paclitaxel

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PACLITAXEL;

EID: 79955931060     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i8.1082     Document Type: Article
Times cited : (16)

References (33)
  • 2
    • 67449107078 scopus 로고    scopus 로고
    • Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population
    • Shen X, Zhang J, Yan Y, Yang Y, Fu G, Pu Y. Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population. J oxicol Environ Health A 2009; 72: 759-766
    • (2009) J Oxicol Environ Health A , vol.72 , pp. 759-766
    • Shen, X.1    Zhang, J.2    Yan, Y.3    Yang, Y.4    Fu, G.5    Pu, Y.6
  • 5
    • 4043102535 scopus 로고    scopus 로고
    • Treatment of localized gastric cancer
    • Macdonald JS. Treatment of localized gastric cancer. Semin Oncol 2004; 31: 566-573
    • (2004) Semin Oncol , vol.31 , pp. 566-573
    • Macdonald, J.S.1
  • 6
    • 0027217474 scopus 로고
    • Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
    • Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41
    • (1993) Cancer , vol.72 , pp. 37-41
    • Murad, A.M.1    Santiago, F.F.2    Petroianu, A.3    Rocha, P.R.4    Rodrigues, M.A.5    Rausch, M.6
  • 7
    • 0028959887 scopus 로고
    • Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
    • Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591
    • (1995) Br J Cancer , vol.71 , pp. 587-591
    • Pyrhönen, S.1    Kuitunen, T.2    Nyandoto, P.3    Kouri, M.4
  • 9
    • 0018387446 scopus 로고
    • Promotion of microtubule assembly in vitro by taxol
    • Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667
    • (1979) Nature , vol.277 , pp. 665-667
    • Schiff, P.B.1    Fant, J.2    Horwitz, S.B.3
  • 11
    • 34548241326 scopus 로고    scopus 로고
    • Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 Study Group
    • Ajani JA, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Awad L, Van Cutsem E. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group. J Clin Oncol 2007; 25: 3210-3216
    • (2007) J Clin Oncol , vol.25 , pp. 3210-3216
    • Ajani, J.A.1    Moiseyenko, V.M.2    Tjulandin, S.3    Majlis, A.4    Constenla, M.5    Boni, C.6    Rodrigues, A.7    Fodor, M.8    Chao, Y.9    Voznyi, E.10    Awad, L.11    van Cutsem, E.12
  • 13
    • 36348949070 scopus 로고    scopus 로고
    • A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer
    • Im CK, Jeung HC, Rha SY, Yoo NC, Noh SH, Roh JK, Chung HC. A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer Chemother Pharmacol 2008; 61: 315-321
    • (2008) Cancer Chemother Pharmacol , vol.61 , pp. 315-321
    • Im, C.K.1    Jeung, H.C.2    Rha, S.Y.3    Yoo, N.C.4    Noh, S.H.5    Roh, J.K.6    Chung, H.C.7
  • 15
    • 0033509601 scopus 로고    scopus 로고
    • Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: A novel, safe, and effective regimen
    • Murad AM, Petroianu A, Guimaraes RC, Aragao BC, Cabral LO, Scalabrini-Neto AO. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen. Am J Clin Oncol 1999; 22: 580-586
    • (1999) Am J Clin Oncol , vol.22 , pp. 580-586
    • Murad, A.M.1    Petroianu, A.2    Guimaraes, R.C.3    Aragao, B.C.4    Cabral, L.O.5    Scalabrini-Neto, A.O.6
  • 17
    • 25144444885 scopus 로고    scopus 로고
    • The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: A multicenter phase II study
    • Shin SJ, Chun SH, Kim KO, Kim MK, Lee KH, Hyun MS, Bae SH, Ryoo HM, Do YR, Kwon KY, Song HS. The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: a multicenter phase II study. Korean J Intern Med 2005; 20: 135-140
    • (2005) Korean J Intern Med , vol.20 , pp. 135-140
    • Shin, S.J.1    Chun, S.H.2    Kim, K.O.3    Kim, M.K.4    Lee, K.H.5    Hyun, M.S.6    Bae, S.H.7    Ryoo, H.M.8    Do, Y.R.9    Kwon, K.Y.10    Song, H.S.11
  • 18
    • 0036866047 scopus 로고    scopus 로고
    • Cellular and molecular aspects of drugs of the future: Oxaliplatin
    • Di Francesco AM, Ruggiero A, Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci 2002; 59: 1914-1927
    • (2002) Cell Mol Life Sci , vol.59 , pp. 1914-1927
    • di Francesco, A.M.1    Ruggiero, A.2    Riccardi, R.3
  • 19
    • 0142163708 scopus 로고    scopus 로고
    • A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines
    • Eriguchi M, Nonaka Y, Yanagie H, Yoshizaki I, Takeda Y, Sekiguchi M. A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines. Biomed Pharmacother 2003; 57: 412-415
    • (2003) Biomed Pharmacother , vol.57 , pp. 412-415
    • Eriguchi, M.1    Nonaka, Y.2    Yanagie, H.3    Yoshizaki, I.4    Takeda, Y.5    Sekiguchi, M.6
  • 28
    • 4644274892 scopus 로고    scopus 로고
    • Clinical and experimental study of oxaliplatin in treating human gastric carcinoma
    • Lin WL, Li DG, Chen Q, Lu HM. Clinical and experimental study of oxaliplatin in treating human gastric carcinoma. World J Gastroenterol 2004; 10: 2911-2915
    • (2004) World J Gastroenterol , vol.10 , pp. 2911-2915
    • Lin, W.L.1    Li, D.G.2    Chen, Q.3    Lu, H.M.4
  • 29
    • 0026512446 scopus 로고
    • A chronopharmacologic phase II clinical trial with 5- fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
    • Lévi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, Caussanel JP, Kunstlinger F, Lecouturier S, Descorps-Declère A. A chronopharmacologic phase II clinical trial with 5- fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 1992; 69: 893-900
    • (1992) Cancer , vol.69 , pp. 893-900
    • Lévi, F.1    Misset, J.L.2    Brienza, S.3    Adam, R.4    Metzger, G.5    Itzakhi, M.6    Caussanel, J.P.7    Kunstlinger, F.8    Lecouturier, S.9    Descorps-Declère, A.10
  • 30
    • 0028036652 scopus 로고
    • Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
    • Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 1994; 86: 1608-1617
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1608-1617
    • Lévi, F.A.1    Zidani, R.2    Vannetzel, J.M.3    Perpoint, B.4    Focan, C.5    Faggiuolo, R.6    Chollet, P.7    Garufi, C.8    Itzhaki, M.9    Dogliotti, L.10
  • 33
    • 34848927813 scopus 로고    scopus 로고
    • Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: Results of a phase II trial
    • Lorenzen S, Hentrich M, Haberl C, Heinemann V, Schuster T, Seroneit T, Roethling N, Peschel C, Lordick F. Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol 2007; 18: 1673-1679
    • (2007) Ann Oncol , vol.18 , pp. 1673-1679
    • Lorenzen, S.1    Hentrich, M.2    Haberl, C.3    Heinemann, V.4    Schuster, T.5    Seroneit, T.6    Roethling, N.7    Peschel, C.8    Lordick, F.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.